Abbott announced plans to buy Exact in November, in the largest medtech deal announced last year. Exact makes the Cologuard ...

Abbott broadens cancer diagnostics portfolio through Exact Sciences acquisition; Focus strengthens position within advanced ...

Abbott (NYSE: ABT) today announced that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026. The announcement follows receipt of all regulatory clearances necessary for ...

Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott ...

Abbott (NYSE: ABT) announced today that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four presentations at the 2026 American Association for Cancer Research (AACR) Annual ...

For a third consecutive year, a deal involving a health care-focused company is among the state’s largest mergers and acquisitions of the past year. In ...

Under the collab, Walgreens customers will be able to access tools and resources to better understand their colorectal cancer screening options.

Don't give up on this leading dividend payer yet.

For the quarter ending December 31, 2025, the fund's Retail Class shares gained 3.13%, surpassing the 1.64% advance of the benchmark, the S&P MidCap 400 Index. Read more here.

Among the most buzzworthy inclusions are products from Glow Recipe, the Korean-inspired skincare brand whose dewy, fruit-powered formulas regularly go viral online. This year’s nominees will receive ...

The two leaders said that GE Vernova and Hitachi will build BWRX-300 small modular nuclear reactors in Tennessee and Alabama.